N4 Pharma

(N4P)
Sector: Pharmaceuticals & Biotechnology
0.63p
-0.03p -3.85
Last updated: 16:57:08

Share information

Name N4 Pharma
Epic N4P
Isin GB00BYW8QM32
Industry Pharmaceuticals & Biotechnology

Key numbers

Latest share price 0.63p Net gearing n/a
Market capitalisation £2.47 Debt ratio n/a
Shares in issue 268.78 Debt-to-equity ratio n/a
P/E ratio n/a Assets / equity ratio n/a
Total dividends per share n/a Price to book value n/a
Dividend yield n/a ROCE -57.14
Dividend cover n/a EPS growth n/a
Earning per share -0.55 52-week high / low 0.50p / 3.07p

Dividends

Type Ex-date Pay-date Net-dividend
No dividends declared

Contact details

Company name N4 Pharma
Address 6th Floor, 60 Gracechurch Street, London, United Kingdom, EC3V 0HR
Telephone
Website http://www.n4pharma.com/

Directors

Director Position
Mr Nigel Theobald CEO
Mr Luke Cairns Executive Director
Mr David Templeton Executive Director
Dr Chris Britten Non-Executive Chairman

Company financials

Assets £ (m) 2022 2021 2020
Reporting date 31/12/22 31/12/21 31/12/20
Intangible asssets and goodwill n/a n/a n/a
Investments and other non-current assets n/a n/a n/a
Total non-current assets n/a n/a n/a
Inventory / work in progress n/a n/a n/a
Trade and other receivables 0.25 0.56 0.27
Cash and equivalents 1.92 1.78 3.56
Other current assets and asset held for resale n/a n/a n/a
Total of all assets 2.17 2.34 3.83
Liabilities £ (m) 2022 2021 2020
Short term liabilities 0.08 0.21 0.17
Long term liabilities n/a n/a n/a
Other liabilites / pension etc n/a n/a n/a
Total of all liabilities 0.08 0.21 0.17
Net assets £ (m) 2022 2021 2020
Net assets 2.09 2.13 3.66
Equity £ (m) 2022 2021 2020
Share capital 9.21 9 9
Minority interests n/a n/a n/a
Retained earnings -8.06 -7.03 -5.49
Share premium account 14.7 13.95 13.95
Total equity 2.09 2.13 3.66
Income £ (m) 2022 2021 2020
Turnover n/a n/a n/a
Operating profit -1.19 -1.84 -1.56
Pre-tax profit -1.19 -1.84 -1.57